Please check your internet connection and try again.
# Arsil 25252525252525252525252525252525252525252525252525252525252525252525 20dx
## Overview
Arsil 25252525252525252525252525252525252525252525252525252525252525252525 20dx is a combination medication containing Aspirin and Dipyridamole. Aspirin is an NSAID with antiplatelet effects, and Dipyridamole is a phosphodiesterase inhibitor that also inhibits adenosine uptake, leading to vasodilation and antiplatelet effects.
## Primary Indications
* Prophylaxis of thromboembolic disorders, particularly cerebrovascular events (stroke).
## Adult Dosing
The typical starting dose is one capsule (25 mg aspirin and 200 mg dipyridamole) twice daily.
Many dosing regimens exist and may depend on local protocols and patient response. A common alternative or maintenance regimen, particularly for patients on extended-release formulations, involves one capsule every 12 hours.
## Pediatric Dosing
There is no established pediatric dosing for Arsil 25252525252525252525252525252525252525252525252525252525252525252525 20dx.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Dipyridamole and its metabolites are renally excreted. Data is limited, but dosage reductions may be considered in severe renal impairment.
* **Hepatic Impairment:** Use with caution. No specific dose adjustments are established, but impaired hepatic function may affect drug metabolism.
## Contraindications
* Known hypersensitivity to aspirin, dipyridamole, or any component of the formulation.
* Hemorrhagic diathesis or patients with active, serious bleeding.
* Patients with known or suspected aspirin-induced asthma, urticaria, or allergic rhinitis.
* Use in patients with a known predisposition to bleeding.
* Uncontrolled hypertension.
* Recent myocardial infarction.
## Adverse Effects
* **Common:** Headache, dizziness, gastrointestinal upset (diarrhea, nausea, vomiting, abdominal pain), rash.
* **Serious:** Bleeding (gastrointestinal, intracranial), bronchospasm, severe hypersensitivity reactions.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, direct oral anticoagulants):** Increased risk of bleeding.
* **Other Antiplatelets (e.g., clopidogrel, prasugrel):** Increased risk of bleeding.
* **NSAIDs:** Increased risk of gastrointestinal bleeding and renal impairment.
* **Adenosine:** Dipyridamole potentiates the effects of adenosine, potentially leading to exaggerated bradycardia and hypotension. If adenosine is administered, dipyridamole should be discontinued for at least 24 hours prior.
* **Cholinesterase Inhibitors:** May decrease the effectiveness of dipyridamole.
## Monitoring
* **Bleeding:** Monitor for signs and symptoms of bleeding (e.g., ecchymosis, epistaxis, hematuria, melena, hematemesis).
* **Renal Function:** Assess periodically, especially in patients with pre-existing renal disease or those at risk.
* **Hepatic Function:** Assess periodically, especially in patients with pre-existing hepatic disease.
* **Blood Pressure:** Monitor, particularly given the risk of hypotension with dipyridamole.
## Clinical Pearls
* This fixed-dose combination is often used for secondary stroke prevention.
* Dipyridamole can cause significant headaches, which may limit its tolerability.
* Aspirin should be used cautiously in patients with a history of peptic ulcer disease due to the increased risk of GI bleeding.
* Patients should be advised to report any signs of bleeding or unusual bruising.
* The extended-release formulation of dipyridamole in combination with aspirin may have different dosing recommendations and should be verified.
***
*Disclaimer: This information is intended for clinical professionals and is not exhaustive. Always consult the current prescribing information and relevant clinical guidelines before initiating or modifying therapy. Dosing and recommendations may vary based on individual patient factors and local protocols.*
